Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease

Inflamm Bowel Dis. 2023 Sep 1;29(9):e37. doi: 10.1093/ibd/izad088.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biological Products* / therapeutic use
  • Crohn Disease*
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Prior Authorization

Substances

  • Biological Products